ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Titan Biotech Ltd reported revenue from operations of ₹76.5 Cr (+40.6% YoY) and net profit of ₹12.5 Cr (+60.3% YoY) for Q2 FY27.
Titan Biotech's board meets 05 November 2026 to consider unaudited quarterly and half-year results. Trading window stays closed until 48 hours after outcome declaration.
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Titan Biotech Ltd fixed October 23, 2026, as the record date for its 1:4 bonus share issue. Allotment is scheduled for October 26, 2026.
Titan Biotech increased its authorised share capital from Rs. 10 Crore to Rs. 10.40 Crore, following shareholder approval at the 34th Annual General Meeting.
Titan Biotech Limited held its 34th Annual General Meeting on September 29, 2026. The meeting transacted ordinary and special business, including financial adoption and director appointments.
Titan Biotech has dispatched letters to shareholders with unregistered emails, providing web links to access the FY 2025-26 Annual Report and 34th AGM Notice.
Titan Biotech filed its 34th Annual Report and AGM Notice for the financial year 2025-26. The AGM is scheduled for September 29, 2026.
Titan Biotech Limited has fixed September 22, 2026, as the record date for a final dividend of ₹0.50 per share. The payout remains subject to shareholder approval.
Titan Biotech Limited will hold its 34th Annual General Meeting on September 29, 2026. The company set September 22, 2026, as the record date for final dividend eligibility.
Titan Biotech Limited approved a 1:4 bonus issue and increased its authorised share capital to Rs. 10.40 Crore. The bonus issue is subject to shareholder approval at the upcoming AGM.
Titan Biotech Ltd has scheduled a board meeting on September 3, 2026, to consider a bonus share issue and plan the 34th Annual General Meeting.
Titan Biotech Ltd reported revenue from operations of ₹59.2 Cr (+27.3% YoY) and net profit of ₹10.9 Cr (+58.0% YoY) for Q1 FY27.